Belgian radiopharmaceutical firm Ion Beam Applications (IBA) of Louvain-la-Neuve has received the go-ahead from U.K. authorities to begin operations at its new PET radiopharmaceuticals production site in Guildford, U.K., according to the company.
The facility will serve the south of England, and is the fourth production site IBA has opened in Europe in the last year. IBA has 18 operational European centers, the company said.
Related Reading
IBA posts mixed results for 2007, March 7, 2008
IBA inks French particle-beam therapy deal, February 7, 2008
IBA finalizes proton therapy deal, December 21, 2007
FDA OKs Compass dosimetry device, December 18, 2007
IBA sells cyclotron to Saudi Arabia, December 4, 2007
Copyright © 2008 AuntMinnie.com
